These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28348767)

  • 21. Epidemiological characteristics of cryptococcal meningoencephalitis associated with Cryptococcus neoformans var. grubii from HIV-infected patients in Madagascar: A cross-sectional study.
    Rakotoarivelo RA; Raberahona M; Rasamoelina T; Rabezanahary A; Rakotomalala FA; Razafinambinintsoa T; Bénet T; Vanhems P; Randria MJD; Romanò L; Cogliati M; Cornet M; Rakoto Andrianarivelo M
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007984. PubMed ID: 31929533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antifungal susceptibility profiles of Cryptococcus species isolated from HIV-associated cryptococcal meningitis patients in Zimbabwe.
    Nyazika TK; Herkert PF; Hagen F; Mateveke K; Robertson VJ; Meis JF
    Diagn Microbiol Infect Dis; 2016 Nov; 86(3):289-292. PubMed ID: 27608538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype and mating type distribution within clinical Cryptococcus neoformans and Cryptococcus gattii isolates from patients with cryptococcal meningitis in Uberaba, Minas Gerais, Brazil.
    Mora DJ; Pedrosa AL; Rodrigues V; Leite Maffei CM; Trilles L; Dos Santos Lazéra M; Silva-Vergara ML
    Med Mycol; 2010 Jun; 48(4):561-9. PubMed ID: 19905964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotyping Analysis of
    Andrade-Silva LE; Vilas-Boas A; Ferreira-Paim K; Andrade-Silva J; Santos DA; Ferreira TB; Borges AS; Mora DJ; Melhem MSC; Silva-Vergara ML
    J Fungi (Basel); 2023 Aug; 9(9):. PubMed ID: 37754997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility testing of amphotericin B for Cryptococcus neoformans variety grubii AFLP1/VNI and Cryptococcus gattii AFLP6/VGII by CLSI and flow cytometry.
    Morales BP; Trilles L; Bertho ÁL; Junior IN; de Oliveira Rde V; Wanke B; Lazéra Mdos S
    Mycoses; 2015 May; 58(5):273-9. PubMed ID: 25756839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiological, Epidemiological, and Clinical Characteristics of Patients With Cryptococcal Meningitis at a Tertiary Hospital in China: A 6-Year Retrospective Analysis.
    Li Y; Zou M; Yin J; Liu Z; Lu B
    Front Microbiol; 2020; 11():1837. PubMed ID: 32849436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversity and Antifungal Drug Susceptibility of Cryptococcus Isolates in Thailand.
    Worasilchai N; Tangwattanachuleeporn M; Meesilpavikkai K; Folba C; Kangogo M; Groß U; Weig M; Bader O; Chindamporn A
    Med Mycol; 2017 Aug; 55(6):680-685. PubMed ID: 27915307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
    Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
    Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular characterization of Cryptococcus neoformans isolates from HIV patients, Guayaquil, Ecuador].
    Sánchez S; Zambrano D; García M; Bedoya C; Fernández C; Illnait-Zaragozí MT
    Biomedica; 2017 Sep; 37(3):425-430. PubMed ID: 28968020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of clinical isolates of the Cryptococcus neoformans-Cryptococcus gattii species complex from the Amazonas State in Brazil.
    Da Silva BK; Freire AK; Bentes Ados S; Sampaio Ide L; Santos LO; Dos Santos MS; De Souza JV
    Rev Iberoam Micol; 2012; 29(1):40-3. PubMed ID: 21699993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of Cryptococcus neoformans isolated from the environment in Beijing, China.
    Dou H; Wang H; Xie S; Chen X; Xu Z; Xu Y
    Med Mycol; 2017 Oct; 55(7):737-747. PubMed ID: 28431114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatal Cryptococcus gattii genotype AFLP6/VGII infection in a HIV-negative patient: case report and a literature review.
    Favalessa OC; Lázera Mdos S; Wanke B; Trilles L; Takahara DT; Tadano T; Dias LB; Vieira AC; Novack GV; Hahn RC
    Mycoses; 2014 Oct; 57(10):639-43. PubMed ID: 24980291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. African ST173 Cryptococcus deuterogattii strains are commonly less susceptible to fluconazole: An unclear mechanism of resistance.
    Bertout S; Roger F; Drakulovski P; Martin AS; Gouveia T; Kassi F; Menan H; Krasteva D; Delaporte E; Bellet V
    J Glob Antimicrob Resist; 2020 Jun; 21():262-269. PubMed ID: 31711926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotyping of Cryptococcus neoformans isolated from captive birds in Uberaba, Minas Gerais, Brazil.
    Ferreira-Paim K; Andrade-Silva L; Mora DJ; Pedrosa AL; Rodrigues V; Silva-Vergara ML
    Mycoses; 2011 Sep; 54(5):e294-300. PubMed ID: 20492533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
    González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
    Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia.
    Escandón P; Sánchez A; Martínez M; Meyer W; Castañeda E
    FEMS Yeast Res; 2006 Jun; 6(4):625-35. PubMed ID: 16696659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.
    Herkert PF; Hagen F; de Oliveira Salvador GL; Gomes RR; Ferreira MS; Vicente VA; Muro MD; Pinheiro RL; Meis JF; Queiroz-Telles F
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1803-1810. PubMed ID: 27477855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.